EZH2 and gastric cancer: Evidence from in vitro and in vivo models of GC has demonstrated that the interactions between EZH2 and these lncRNAs modulate a range of biological processes, including drug resistance, cellular migration and invasion, metastatic progression, and the regulation of the cell cycle.